JPH06199648A - Solubilized cosmetic - Google Patents
Solubilized cosmeticInfo
- Publication number
- JPH06199648A JPH06199648A JP5001671A JP167193A JPH06199648A JP H06199648 A JPH06199648 A JP H06199648A JP 5001671 A JP5001671 A JP 5001671A JP 167193 A JP167193 A JP 167193A JP H06199648 A JPH06199648 A JP H06199648A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- zinc
- salt
- compound
- salt compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- -1 salt compound Chemical class 0.000 claims abstract description 44
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 12
- 150000001735 carboxylic acids Chemical class 0.000 claims abstract description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 17
- 239000013522 chelant Substances 0.000 claims description 16
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 12
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 12
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 10
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 10
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 10
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 abstract description 12
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 9
- 238000013329 compounding Methods 0.000 abstract description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract description 3
- 235000006408 oxalic acid Nutrition 0.000 abstract description 3
- 239000011975 tartaric acid Substances 0.000 abstract description 3
- 235000002906 tartaric acid Nutrition 0.000 abstract description 3
- 239000011592 zinc chloride Substances 0.000 abstract description 2
- 235000005074 zinc chloride Nutrition 0.000 abstract description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 abstract description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 abstract description 2
- 229960001763 zinc sulfate Drugs 0.000 abstract description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 abstract description 2
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 abstract description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 abstract 4
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 abstract 2
- 229960003720 enoxolone Drugs 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 235000014304 histidine Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 238000000034 method Methods 0.000 description 16
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 239000006210 lotion Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 229940074774 glycyrrhizinate Drugs 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000005562 fading Methods 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 239000004034 viscosity adjusting agent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004902 Softening Agent Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N iso-octadecanoic acid Natural products CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- MDVYIGJINBYKOM-UHFFFAOYSA-N 3-[[5-Methyl-2-(1-methylethyl)cyclohexyl]oxy]-1,2-propanediol Chemical compound CC(C)C1CCC(C)CC1OCC(O)CO MDVYIGJINBYKOM-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は可溶化型化粧料、更に詳
細には亜鉛イオンをカルボン酸又はその塩とキレートさ
せることにより、グリチルリチン酸の塩化合物を沈澱さ
せることなく配合することのできる、収れん効果と抗炎
症効果に優れ、安定性の良好な可溶化型化粧料に関す
る。FIELD OF THE INVENTION The present invention relates to a solubilized cosmetic composition, more specifically, by chelating zinc ions with a carboxylic acid or a salt thereof, a glycyrrhizic acid salt compound can be compounded without precipitation. The present invention relates to a solubilized cosmetic composition having excellent astringent effect and anti-inflammatory effect and excellent stability.
【0002】[0002]
【従来の技術】一般に、化粧水や美容液等の可溶化型化
粧料は、洗顔料等により皮膚に付着した汚垢を充分に取
り去った後に塗布し、皮膚の角質層に適度な水分や保湿
成分を供給して皮膚の生理活性を整える目的で用いられ
ている。2. Description of the Related Art Generally, solubilizing cosmetics such as lotions and beauty essences are applied after thoroughly removing dirt adhering to the skin with a facial cleanser etc., so that the stratum corneum of the skin is appropriately moisturized and moisturized. It is used for the purpose of supplying ingredients to regulate the physiological activity of the skin.
【0003】現在使用されている可溶化型化粧料は、使
用する人の肌の質、その肌の状態、季節あるいは用途等
に合わせて柔軟化粧水、収れん化粧水、洗浄化粧水等に
区別されている。このうち、収れん化粧水等の収れん作
用を備えた化粧料は、配合されている収れん剤によって
皮膚の過剰な油分の分泌を抑えるか、あるいは水分量を
整えることによって、皮膚をひきしめる効果を目的とす
るものである。Solubilized cosmetics currently in use are classified into soft lotion, astringent lotion, cleansing lotion, etc. according to the quality of the skin of the user, the condition of the skin, the season or the intended use. ing. Among them, cosmetics having astringent action such as astringent lotion are intended to have an effect of tightening the skin by suppressing excessive secretion of oil in the skin by adjusting the astringent contained therein or adjusting the water content. To do.
【0004】従来、かかる化粧料には、収れん効果を得
るために、亜鉛に代表される二価金属類の塩化合物が収
れん剤として配合されてきた。また、皮膚に過剰の油分
と水分が存在すると肌は炎症を起こしやすい状態となる
ためこれを抑える目的でグリチルリチン酸の塩化合物が
配合されてきた。Conventionally, in order to obtain an astringent effect, a salt compound of a divalent metal represented by zinc has been blended as an astringent in such cosmetics. Further, when excess oil and water are present in the skin, the skin is likely to be inflamed, so that a salt compound of glycyrrhizic acid has been blended for the purpose of suppressing the inflammation.
【0005】しかしながら、水溶液中で亜鉛イオンを生
成する化合物とグリチルリチン酸の塩化合物とを同時に
配合した場合には、不溶性のグリチルリチン酸亜鉛が形
成され、その沈澱を生じるという問題があった。However, when a compound that produces zinc ions in an aqueous solution and a salt compound of glycyrrhizic acid are simultaneously mixed, there is a problem that insoluble zinc glycyrrhizinate is formed and its precipitation occurs.
【0006】[0006]
【発明が解決しようとする課題】従って、水溶液中で亜
鉛イオンを生成する化合物とグリチルリチン酸の塩化合
物とを含有して優れた収れん作用を有すると共に、グリ
チルリチン酸の塩化合物の沈澱を生じず安定性の良好な
化粧料の開発が望まれていた。Therefore, the compound containing a zinc ion-forming compound and a salt compound of glycyrrhizic acid in an aqueous solution has an excellent astringent action and is stable without causing precipitation of the salt compound of glycyrrhizinate. It has been desired to develop a cosmetic having good properties.
【0007】[0007]
【課題を解決するための手段】かかる実情において、本
発明者らは鋭意研究を行った結果、亜鉛イオンを含有す
る化粧料に、亜鉛イオンと特定のキレート定数を有する
カルボン酸又はその塩を加えて、亜鉛イオンとカルボン
酸とのキレート化合物を生成させれば、グリチルリチン
酸の塩化合物を沈澱させることなく配合することができ
ると共に、収れん効果を有し、かつ安定性の良好な化粧
料が得られることを見出し、本発明を完成した。Under the circumstances, as a result of intensive studies by the present inventors, as a result of adding carboxylic acid having zinc ion and a specific chelate constant or a salt thereof to a cosmetic containing zinc ion. By forming a chelate compound of zinc ion and carboxylic acid, a salt compound of glycyrrhizinic acid can be compounded without precipitation, and a cosmetic product having an astringent effect and good stability can be obtained. Therefore, the present invention has been completed.
【0008】すなわち、本発明は次の成分(a)、
(b)及び(c) (a)水溶液中で亜鉛イオンを生成する化合物 (b)グリチルリチン酸の塩化合物 (c)亜鉛イオンとのキレート定数が10-2〜10-6で
あるカルボン酸及びその塩から選ばれる一種又は二種以
上を含有することを特徴とする可溶化型化粧料を提供す
るものである。That is, the present invention provides the following component (a),
(B) and (c) (a) Compound that produces zinc ion in aqueous solution (b) Salt compound of glycyrrhizic acid (c) Carboxylic acid having chelate constant with zinc ion of 10 -2 to 10 -6 and its The present invention provides a solubilized cosmetic composition, which comprises one or more selected from salts.
【0009】尚、本発明において、可溶化型とはグリチ
ルリチン酸の塩化合物の沈澱が生じない状態を意味し、
またキレート定数とは、下記(1)に示す反応によって
キレート(ApBq) が生成するときに、(2)で示される
式によって導かれるキレートの生成定数を意味する。In the present invention, the solubilized type means a state in which the salt compound of glycyrrhizic acid does not precipitate,
The chelate constant means a chelate formation constant derived from the formula (2) when a chelate (A p B q ) is formed by the reaction shown in (1) below.
【0010】[0010]
【数1】 [Equation 1]
【0011】〔式中、Aは亜鉛イオンを示し、Bは配位
子であるカルボン酸を示し、Kはキレート定数を示す〕[In the formula, A represents a zinc ion, B represents a carboxylic acid as a ligand, and K represents a chelate constant.]
【0012】本発明における(a)成分の水溶液中で亜
鉛イオンを生成する化合物としては、従来より化粧料等
に収れん剤として配合されてきたものであれば特に限定
されず、硫酸亜鉛、塩化亜鉛、ステアリン酸亜鉛、ラウ
リン酸亜鉛、p−フェノールスルホン酸亜鉛等の亜鉛の
塩化合物や酸化亜鉛などが挙げられる。The compound which produces zinc ions in the aqueous solution of the component (a) in the present invention is not particularly limited as long as it has been conventionally blended in cosmetics and the like as an astringent, and zinc sulfate, zinc chloride. , Zinc stearate, zinc laurate, zinc p-phenolsulfonate, and other zinc salt compounds, and zinc oxide.
【0013】(a)成分は、これらの化合物の中から任
意に選択したものの一種を単独で又は二種以上を組み合
わせて用いることができ、その配合量は化粧料全量中に
0.001〜5重量%、特に0.01〜1.0重量%が
好ましい。As the component (a), one selected from these compounds can be used alone or in combination of two or more, and the compounding amount thereof is 0.001 to 5 in the total amount of the cosmetic. %, Especially 0.01 to 1.0% by weight is preferred.
【0014】また、本発明における(b)成分のグリチ
ルリチン酸の塩化合物としては、化粧料の配合成分とし
て一般的に用いられているものであれば特に限定され
ず、具体的にはグリチルリチン酸のジカリウム塩、アン
モニウム塩等が挙げられる。Further, the salt compound of glycyrrhizic acid, which is the component (b) in the present invention, is not particularly limited as long as it is a compound generally used as a blending component of cosmetics. Examples thereof include dipotassium salt and ammonium salt.
【0015】(b)成分のグリチルリチン酸の塩化合物
は一種を単独で又は二種以上を組み合わせて用いること
ができ、その配合量は化粧料全量中に0.01〜1重量
%、特に0.5重量%が好ましい。The glycyrrhizic acid salt compound as the component (b) can be used alone or in combination of two or more kinds, and the compounding amount thereof is 0.01 to 1% by weight, and particularly 0.1% by weight based on the total amount of the cosmetic. 5% by weight is preferred.
【0016】更に、本発明の(c)成分のカルボン酸又
はその塩は、亜鉛イオンとのキレート定数が10-2〜1
0-6となるものであれば特に限定されるものではない。
ここでキレート定数が10-2以上では(a)成分と
(b)成分が反応してグリチルリチン酸亜鉛の沈澱が生
じてしまい、また、キレート定数が10-6未満であると
亜鉛イオンによる収れん効果が損われてしまう。(c)
成分のカルボン酸の具体例としは、クエン酸、酒石酸、
乳酸、リンゴ酸などのヒドロキシカルボン酸、シュウ
酸、コハク酸などのジカルボン酸、ヒスチジンなどのア
ミノ酸等が挙げられ、またその塩としてはナトリウム
塩、カリウム塩、アンモニウム塩等が挙げられる。Further, the carboxylic acid or salt thereof of the component (c) of the present invention has a chelate constant with zinc ion of 10 -2 to 1.
There is no particular limitation as long as it is 0 −6 .
Here, when the chelate constant is 10 -2 or more, the components (a) and (b) react with each other to cause precipitation of zinc glycyrrhizinate, and when the chelate constant is less than 10 -6 , a convergence effect due to zinc ions is obtained. Will be damaged. (C)
Specific examples of the carboxylic acid as a component include citric acid, tartaric acid,
Examples thereof include hydroxycarboxylic acids such as lactic acid and malic acid, dicarboxylic acids such as oxalic acid and succinic acid, amino acids such as histidine, and the salts thereof include sodium salt, potassium salt, ammonium salt and the like.
【0017】(c)成分のカルボン酸又はその塩は一種
を単独又は二種以上を組み合わせて用いることができ、
その配合量は化粧料全量中に0.01〜5重量%が好ま
しい。また、(c)成分のカルボン酸又はその塩は
(a)成分に対して重量モル比で(c)/(a)=1/
1〜20/1となる量で配合されるのが好ましい。The carboxylic acid or salt thereof as the component (c) may be used alone or in combination of two or more,
The blending amount thereof is preferably 0.01 to 5% by weight based on the total amount of the cosmetic. Further, the carboxylic acid or the salt thereof as the component (c) has a weight molar ratio of (c) / (a) = 1 / to the component (a).
It is preferably blended in an amount of 1 to 20/1.
【0018】本発明の可溶化型化粧料は、(a)成分に
由来する亜鉛イオンと(c)成分のカルボン酸又はその
塩とが水溶性のキレート化合物を形成することにより、
(b)成分のグリチルリチン酸の塩化合物が亜鉛イオン
と塩を形成しないため、グリチルリチン酸の塩化合物の
沈澱を生じさせることなく(a)成分と(b)成分を配
合することができるものである。In the solubilized cosmetic of the present invention, zinc ions derived from the component (a) and the carboxylic acid or the salt thereof as the component (c) form a water-soluble chelate compound.
Since the salt compound of glycyrrhizic acid as the component (b) does not form a salt with zinc ions, the component (a) and the component (b) can be blended without causing precipitation of the salt compound of glycyrrhizinate. .
【0019】尚、本発明の化粧料には必要に応じ、本発
明の効果を損わない範囲において、上記必須成分以外の
通常化粧品、医薬部外品、医薬品等に用いられる各種任
意成分を配合することができる。If necessary, the cosmetic of the present invention may contain various optional components used in ordinary cosmetics, quasi drugs, pharmaceuticals, etc. other than the above-mentioned essential components, as long as the effects of the present invention are not impaired. can do.
【0020】かかる任意成分としては、例えば精製水、
アルコール、保湿剤、角質軟化剤、界面活性剤、粘度調
節剤、薬効剤、褪色防止剤、色素、香料、防腐剤、感触
改善剤等が挙げられ、具体的にはアルコールとしてはエ
タノール等が挙げられ、保湿剤としてはグリセリン、プ
ロピレングリコール、ジプロピレングリコール、1,3
−ブチレングリコール、ポリエチレングリコール、アミ
ノ酸等が挙げられ、角質軟化剤としては尿素等が挙げら
れ、界面活性剤としてはポリオキシエチレンアルキルエ
ーテル、ポリオキシエチレン脂肪酸エステル、ポリオキ
シエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ
油、ポリオキシエチレングルタミン酸、ポリオキシエチ
レンイソステアリン酸ジエステル、ポリオキシエチレン
ラウリルエーテル、ポリオキシエチレンヘキシルデシル
エーテルなどの非イオン界面活性剤等が挙げられ、粘度
調節剤としてはキサンタンガムなどの天然ガム質、メチ
ルセルロースなどの高分子化合物等が挙げられ、薬効剤
としては4−イソプロピル−3−メチルフェノール、2
−フェノキシエタノールなどの抗菌・殺菌剤、dl−ト
コフェロールやピリドキシンなどのビタミン類等が挙げ
られ、褪色防止剤としては紫外線吸収剤等が挙げられ、
防腐剤としてはメチルパラベン、エチルパラベン等が挙
げられ、感触改善剤としては動植物エキス、3−1−メ
トキシプロパン−1,2−ジオール等が挙げられる。Examples of such optional components include purified water,
Examples include alcohols, moisturizers, keratin softeners, surfactants, viscosity modifiers, medicinal agents, anti-fading agents, pigments, fragrances, preservatives, and texture-improving agents. Specific examples of alcohols include ethanol. As a moisturizer, glycerin, propylene glycol, dipropylene glycol, 1,3
-Butylene glycol, polyethylene glycol, amino acids and the like, keratin softening agents such as urea, and surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene castor oil, polyoxyethylene. Non-ionic surfactants such as hydrogenated castor oil, polyoxyethylene glutamic acid, polyoxyethylene isostearic acid diester, polyoxyethylene lauryl ether, polyoxyethylene hexyl decyl ether, etc., and natural gums such as xanthan gum as a viscosity modifier. Quality, high molecular compounds such as methyl cellulose, and the like, and 4-isopropyl-3-methylphenol, 2
-Antibacterial / bactericidal agents such as phenoxyethanol, vitamins such as dl-tocopherol and pyridoxine, and examples of anti-fading agents include ultraviolet absorbers,
Preservatives include methylparaben, ethylparaben and the like, and texture improvers include animal and plant extracts, 3-1-methoxypropane-1,2-diol and the like.
【0021】本発明の可溶化型化粧料は常法により製造
することができ、化粧水、美容液等の種々の可溶化系の
剤型とすることができる。The solubilized cosmetic of the present invention can be produced by a conventional method, and can be made into various solubilized dosage forms such as lotion and beauty essence.
【0022】[0022]
【発明の効果】本発明の可溶化型化粧料は亜鉛イオンと
カルボン酸とを適度にキレートさせることにより、グリ
チルリチン酸の塩化合物を沈澱させることなく配合する
ことができるため、長期保存においても良好な安定性を
有すると共に、優れた収れん効果と抗炎症効果を有する
ものである。EFFECTS OF THE INVENTION The solubilized cosmetic composition of the present invention can be blended without causing precipitation of the salt compound of glycyrrhizic acid by appropriately chelating zinc ions and carboxylic acid, and thus is good for long-term storage. It has excellent stability, and also has an excellent astringent effect and anti-inflammatory effect.
【0023】[0023]
【実施例】以下に実施例を挙げて本発明を更に詳細に説
明するが、本発明はこれらによって何ら限定されるもの
ではない。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
【0024】実施例1 表1に示す組成の化粧料を下記の製法に従って調製し、
それぞれについて下記の方法により、収れん効果及び安
定性の評価を行った。結果を表1に示す。Example 1 A cosmetic having the composition shown in Table 1 was prepared according to the following production method,
The astringent effect and stability were evaluated for each of the following methods. The results are shown in Table 1.
【0025】(製法)(1)と(2)のカルボン酸とを
(4)に完全に溶解した後、これに(3)を加え溶解し
た。 (収れん効果の評価方法)各化粧料を被験者の目元に塗
布し、ひきしめ感の有無を次の3段階の評価基準に従っ
て官能評価した。 ○:ひきしまる。 △:ややひきしまる。 ×:ひきしまらない。 (安定性の評価方法)各化粧料を室温又は−5℃にて1
週間保存した際のグリチルリチン酸の塩化合物の沈澱の
有無を目視で観察し、次の3段階の評価基準に従って評
価した。 ○:変化なし。 △:1週間後には沈澱を生じていた。 ×:製造直後に沈澱を生じた。(Production Method) The carboxylic acids of (1) and (2) were completely dissolved in (4), and then (3) was added thereto and dissolved. (Evaluation method of astringent effect) Each cosmetic was applied to the eyes of a subject, and the presence or absence of tightness was sensory evaluated according to the following three-level evaluation criteria. ○: Hikimaru. Δ: Slightly tight. ×: Does not attract. (Stability evaluation method) Each cosmetic is applied at room temperature or -5 ° C for 1
The presence or absence of precipitation of a salt compound of glycyrrhizinic acid when stored for a week was visually observed and evaluated according to the following three-step evaluation criteria. ◯: No change. Δ: Precipitation occurred after 1 week. X: Precipitation occurred immediately after production.
【0026】[0026]
【表1】 [Table 1]
【0027】表1の結果から明らかな如く、本発明品は
収れん効果、安定性共に優れている。As is clear from the results shown in Table 1, the product of the present invention has excellent astringent effect and stability.
【0028】実施例2 表2に示す組成の化粧水を下記の製法に従って調製し、
実施例1と同様の方法により収れん効果の評価を行っ
た。結果を表2に示す。Example 2 A lotion having the composition shown in Table 2 was prepared according to the following method.
The astringent effect was evaluated by the same method as in Example 1. The results are shown in Table 2.
【0029】(製法)(5)と(1)と(2)あるいは
(5)と(3)と(4)を(7)に溶解した後、これに
(6)を加えて溶解した。(Manufacturing method) After dissolving (5), (1) and (2) or (5), (3) and (4) in (7), (6) was added thereto and dissolved.
【0030】[0030]
【表2】 [Table 2]
【0031】表2の結果から明らかな如く、本発明品は
収れん効果に優れるのに反し、キレート定数が10-6よ
り小さいカルボン酸を配位子にした場合は亜鉛イオンに
よる収れん効果が得られなくなる。As is clear from the results shown in Table 2, the product of the present invention is excellent in the astringent effect, whereas when a carboxylic acid having a chelate constant smaller than 10 -6 is used as a ligand, the astringent effect by zinc ion is obtained. Disappear.
【0032】実施例3 表3に示す組成の美容液を下記の方法に従って調製し、
実施例1と同様の方法により収れん効果と安定性の評価
を行ったところ、収れん効果並びに室温及び−5℃にお
ける安定性のすべてについて優れるものであった。Example 3 A serum having the composition shown in Table 3 was prepared according to the following method,
When the astringent effect and the stability were evaluated by the same method as in Example 1, all of the astringent effect and the stability at room temperature and −5 ° C. were excellent.
【0033】(製法)(3)〜(6)を(9)に溶解
し、更に(7)と(8)を加えて完全に溶解したもの
を、(2)を(1)に加えてよく膨潤させたものに静か
に添加し、混合した。(Manufacturing method) (3) to (6) are dissolved in (9), (7) and (8) are further added and completely dissolved, and (2) may be added to (1). To the swollen one was gently added and mixed.
【0034】[0034]
【表3】 [Table 3]
【0035】実施例4 表4に示す組成の化粧水を下記の方法に従って調製し、
実施例1と同様の方法により収れん効果と安定性の評価
を行ったところ、収れん効果並びに室温及び−5℃にお
ける安定性のすべてについて優れるものであった。Example 4 A lotion having the composition shown in Table 4 was prepared according to the following method,
When the astringent effect and the stability were evaluated by the same method as in Example 1, all of the astringent effect and the stability at room temperature and −5 ° C. were excellent.
【0036】(製法)(1)〜(3)を(13)に加え
て完全に溶解したものに、(4)〜(11)を混合して
透明になったものを加え、次いで(12)を添加して完
全に溶解した。(Manufacturing method) (1) to (3) were added to (13) and completely dissolved, to which was added (4) to (11) a mixture which became transparent, and then (12). Was completely dissolved.
【0037】[0037]
【表4】 [Table 4]
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成5年1月20日[Submission date] January 20, 1993
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0015[Name of item to be corrected] 0015
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0015】(b)成分のグリチルリチン酸の塩化合物
は一種を単独で又は二種以上を組み合わせて用いること
ができ、その配合量は化粧料全量中に0.01〜1重量
%が好ましい。The salt compound of glycyrrhizic acid as the component (b) can be used alone or in combination of two or more, and the compounding amount thereof is preferably 0.01 to 1% by weight based on the total amount of the cosmetic.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0016[Correction target item name] 0016
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0016】更に、本発明の(c)成分のカルボン酸又
はその塩は、亜鉛イオンとのキレート定数が10−2〜
10−6となるものであれば特に限定されるものではな
い。ここでキレート定数が10−2以上では(a)成分
と(b)成分が反応してグリチルリチン酸亜鉛の沈澱が
生じてしまい、また、キレート定数が10−6未満であ
ると亜鉛イオンによる収れん効果が損われてしまう。
(c)成分のカルボン酸の具体例としては、クエン酸、
酒石酸、乳酸、リンゴ酸などのヒドロキシカルボン酸、
シュウ酸、コハク酸などのジカルボン酸、ヒスチジンな
どのアミノ酸等が挙げられ、またその塩としてはナトリ
ウム塩、カリウム塩、アンモニウム塩等が挙げられる。Further, the carboxylic acid or salt thereof of the component (c) of the present invention has a chelate constant with zinc ion of 10 −2 to.
There is no particular limitation as long as it is 10 −6 . Here, when the chelate constant is 10 −2 or more, the components (a) and (b) react with each other to cause precipitation of zinc glycyrrhizinate, and when the chelate constant is less than 10 −6 , the astringent effect due to zinc ions is obtained. Will be damaged.
Specific examples of the carboxylic acid as the component (c) include citric acid,
Hydroxycarboxylic acids such as tartaric acid, lactic acid, malic acid,
Examples thereof include dicarboxylic acids such as oxalic acid and succinic acid, amino acids such as histidine, and salts thereof, such as sodium salt, potassium salt, and ammonium salt.
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0020[Correction target item name] 0020
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0020】かかる任意成分としては、例えば精製水、
アルコール、保湿剤、角質軟化剤、界面活性剤、粘度調
節剤、薬効剤、褪色防止剤、色素、香料、防腐剤、感触
改善剤等が挙げられ、具体的にはアルコールとしてはエ
タノール等が挙げられ、保湿剤としてはグリセリン、プ
ロピレングリコール、ジブロピレングリコール、1,3
−ブチレングリコール、ポリエチレングリコール、アミ
ノ酸等が挙げられ、角質軟化剤としては尿素等が挙げら
れ、界面活性剤としてはポリオキシエチレンアルキルエ
ーテル、ポリオキシエチレン脂肪酸エステル、ポリオキ
シエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ
油、ポリオキシエチレングルタミン酸、ポリオキシエチ
レンイソステアリン酸ジエステル、ポリオキシエチレン
ラウリルエーテル、ポリオキシエチレンヘキシルデシル
エーテルなどの非イオン界面活性剤等が挙げられ、粘度
調節剤としてはキサンタンガムなどの天然ガム質、メチ
ルセルロースなどの高分子化合物等が挙げられ、薬効剤
としては4−イソプロピルー3−メチルフェノール、2
−フェノキシエタノールなどの抗菌・殺菌剤、dl−ト
コフェロールやピリドキシンなどのビタミン類等が挙げ
られ、褪色防止剤としては紫外線吸収剤等が挙げられ、
防腐剤としてはメチルパラベン、エチルパラベン等が挙
げられ、感触改善剤としては動植物エキス、3−1−メ
ントキシプロパン−1,2−ジオール等が挙げられる。Examples of such optional components include purified water,
Examples include alcohols, moisturizers, keratin softeners, surfactants, viscosity modifiers, medicinal agents, anti-fading agents, pigments, fragrances, preservatives, and texture-improving agents. Specific examples of alcohols include ethanol. As a moisturizing agent, glycerin, propylene glycol, dipropylene glycol, 1,3
-Butylene glycol, polyethylene glycol, amino acids and the like, keratin softening agents such as urea, and surfactants such as polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene castor oil, polyoxyethylene. Non-ionic surfactants such as hydrogenated castor oil, polyoxyethylene glutamic acid, polyoxyethylene isostearic acid diester, polyoxyethylene lauryl ether, polyoxyethylene hexyl decyl ether, etc., and natural gums such as xanthan gum as a viscosity modifier. And high molecular weight compounds such as methylcellulose, and the like, 4-isopropyl-3-methylphenol, 2
-Antibacterial / bactericidal agents such as phenoxyethanol, vitamins such as dl-tocopherol and pyridoxine, and examples of anti-fading agents include ultraviolet absorbers,
Preservatives include methylparaben, ethylparaben and the like, and texture improvers include animal and plant extracts, 3-1-menthoxypropane-1,2-diol and the like.
【手続補正4】[Procedure amendment 4]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0037[Name of item to be corrected] 0037
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0037】[0037]
【表4】 [Table 4]
Claims (1)
あるカルボン酸及びその塩から選ばれる一種又は二種以
上を含有することを特徴とする可溶化型化粧料。1. The following components (a), (b) and (c) (a) A compound that produces zinc ions in an aqueous solution (b) A salt compound of glycyrrhizic acid (c) A chelate constant with zinc ions is 10. A solubilized cosmetic composition comprising one or more selected from carboxylic acids of −2 to 10 −6 and salts thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5001671A JPH06199648A (en) | 1993-01-08 | 1993-01-08 | Solubilized cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5001671A JPH06199648A (en) | 1993-01-08 | 1993-01-08 | Solubilized cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06199648A true JPH06199648A (en) | 1994-07-19 |
Family
ID=11507986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5001671A Pending JPH06199648A (en) | 1993-01-08 | 1993-01-08 | Solubilized cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06199648A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09301844A (en) * | 1996-03-12 | 1997-11-25 | Shiseido Co Ltd | Solubilized cosmetic material |
FR2829938A1 (en) * | 2001-09-24 | 2003-03-28 | Fabre Pierre Dermo Cosmetique | Dermatological or cosmetic composition for treating inflammatory disorders, especially acne or seborrheic dermatitis, containing synergistic combination of zinc, stearyl or ammonium glycyrrhetinate and lactamide |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS63156728A (en) * | 1986-12-19 | 1988-06-29 | Eisai Co Ltd | Aqueous solution pharmaceutical containing lysozyme chloride and dipotassium glycyrrhetinate |
JPH01163125A (en) * | 1987-12-21 | 1989-06-27 | Shiseido Co Ltd | Anti-inflammatory drug |
JPH03220116A (en) * | 1990-01-03 | 1991-09-27 | Johnson & Johnson Consumer Prod Inc | Stable oral composition of zinc |
-
1993
- 1993-01-08 JP JP5001671A patent/JPH06199648A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5913716A (en) * | 1982-07-16 | 1984-01-24 | Lion Corp | Composition for external use |
JPS63156728A (en) * | 1986-12-19 | 1988-06-29 | Eisai Co Ltd | Aqueous solution pharmaceutical containing lysozyme chloride and dipotassium glycyrrhetinate |
JPH01163125A (en) * | 1987-12-21 | 1989-06-27 | Shiseido Co Ltd | Anti-inflammatory drug |
JPH03220116A (en) * | 1990-01-03 | 1991-09-27 | Johnson & Johnson Consumer Prod Inc | Stable oral composition of zinc |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09301844A (en) * | 1996-03-12 | 1997-11-25 | Shiseido Co Ltd | Solubilized cosmetic material |
FR2829938A1 (en) * | 2001-09-24 | 2003-03-28 | Fabre Pierre Dermo Cosmetique | Dermatological or cosmetic composition for treating inflammatory disorders, especially acne or seborrheic dermatitis, containing synergistic combination of zinc, stearyl or ammonium glycyrrhetinate and lactamide |
WO2003026604A1 (en) * | 2001-09-24 | 2003-04-03 | Pierre Fabre Dermo-Cosmetique | Anti-inflammatory dermocosmetologic composition in particular for treating acne and seborrheic dermatitis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5561264B2 (en) | Hair growth composition | |
JP3446214B2 (en) | Liquid transparent oral composition | |
WO1992005240A1 (en) | Detergent composition | |
JPH07502038A (en) | toothpaste composition | |
KR100789686B1 (en) | Detergent composition | |
JP4934254B2 (en) | Weakly acidic detergent composition | |
JP3570444B2 (en) | Mouthwash | |
JPS5869806A (en) | Cosmetic lotion containing stable collagen | |
JPH06199648A (en) | Solubilized cosmetic | |
JPH05930A (en) | Composition for oral cavity | |
JP2003226636A (en) | Weak-acidic cleansing preparation | |
JP3740090B2 (en) | Water-in-oil external preparation | |
JP4149335B2 (en) | Oral liquid composition and method for producing the same | |
JP2008056703A (en) | Composition for hair restoration | |
JPH07196463A (en) | Composition for oral cavity | |
JP3969587B2 (en) | Azulene sulfonate sodium preparation | |
JPS63297322A (en) | Production of stable ophthalmic solution containing sodium guaiazulenesulfonate | |
JP2001302478A (en) | Liquid composition for oral cavity | |
JPH08259442A (en) | Composition containing urea at high concentration and prevention of crystal deposition of urea | |
JP3045606B2 (en) | Skin cosmetic composition | |
JPH0782127A (en) | Cosmetic | |
JP2627421B2 (en) | Hair cosmetics and method for producing the same | |
JP3020733B2 (en) | Face wash composition | |
JP2023049461A (en) | Liquid skin external composition | |
JPS6393708A (en) | Dissolved composition of benzo-1,2,4-(thiadiazine)-1-dioxide derivative |